نتایج جستجو برای: rrms

تعداد نتایج: 1132  

Journal: :Journal of managed care pharmacy : JMCP 2003
Christina M Meyer Robert Phipps Deborah Cooper Alan Wright

OBJECTIVE To estimate the incremental change in pharmacy per-member-permonth (PMPM) costs, according to various formulary designs, for a new interferon beta-1a product (IB1a2) using administrative claims data. METHODS Cross-sectional sex- and age-specific disease prevalence and treatment rates for relapsing, remitting multiple sclerosis (RRMS) patients were measured using integrated medical a...

Journal: :Multiple sclerosis 2016
J M Tillema H E Hulst M A Rocca H Vrenken M D Steenwijk D Damjanovic C Enzinger S Ropele G Tedeschi A Gallo O Ciccarelli A Rovira X Montalban N de Stefano M L Stromillo M Filippi F Barkhof

OBJECTIVES The objectives of this paper are to compare in a multicenter setting patterns of regional cortical thickness in patients with relapsing-remitting multiple sclerosis (RRMS) and cognitive impairment (CI) and those cognitively preserved (CP), and explore the relationship between cortical thinning and cognitive performance. METHODS T1-weighted isotropic brain scans were collected at 3T...

2017
S Migliore A Ghazaryan I Simonelli P Pasqualetti F Squitieri G Curcio D Landi M G Palmieri F Moffa M M Filippi F Vernieri

Cognitive dysfunction affects 40-65% of multiple sclerosis (MS) patients and can occur in the early stages of the disease. This study aimed to explore cognitive functions by means of the Italian version of the minimal assessment of cognitive function in MS (MACFIMS) in relapsing-remitting MS (RRMS) patients with very mild clinical disability to identify the primarily involved cognitive function...

Journal: :Journal of magnetic resonance imaging : JMRI 2015
Anna I Blazejewska Ali M Al-Radaideh Sam Wharton Su Yin Lim Richard W Bowtell Cris S Constantinescu Penny A Gowland

PURPOSE To study iron deposition in the substantia nigra (SN) and red nuclei (RN), in patients with clinically isolated syndrome (CIS) and relapsing remitting MS (RRMS) and healthy controls (HC). MATERIALS AND METHODS Iron deposition was assessed using susceptibility maps and T2*-w images acquired at high resolution MRI at 7 Tesla (T). Mean intensities were calculated within circular regions ...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014
E Soini C Asseburg M L Sumelahti

Background Multiple sclerosis (MS) is a chronic, progressive, immune-mediated, neurodegenerative disease of the central nervous system, accumulating patient’s disability over time and causing significant human and economic burden. Approximately 80-90% of the incident MS cases are relapsing-remitting MS (RRMS) characterised by phases of remission and relapse. Important goals of the disease-modif...

Journal: :Multiple sclerosis 2015
Niels Bergsland Maria Marcella Laganà Eleonora Tavazzi Matteo Caffini Paola Tortorella Francesca Baglio Giuseppe Baselli Marco Rovaris

BACKGROUND The relationship between white matter injury and cortical atrophy development in relapsing-remitting multiple sclerosis (RRMS) remains unclear. OBJECTIVES To investigate the associations between corticospinal tract integrity and cortical morphology measures of the primary motor cortex in RRMS patients and healthy controls. METHODS 51 RRMS patients and 30 healthy controls underwen...

Journal: :Drug design, development and therapy 2016
Jan Thöne Ralf A Linker

Laquinimod (ABR-215062) is a new orally available carboxamide derivative, which is currently developed for relapsing remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS; RRMS or CPMS) as well as neurodegenerative diseases. Its mechanism of action may comprise immunomodulatory effects on T-cells, monocytes, and dendritic cells as well as neuroprotective effects with promi...

Journal: :Iranian journal of allergy, asthma, and immunology 2015
Fereshteh Alsahebfosoul Ahmad Zavaran Hosseini Rasoul Salehi Masood Etemadifar Nafiseh Esmaeil Azam Jamshidian

Soluble forms of nonclassical human leukocyte antigen (HLA)-G have recently been suggested as immunomodulatory factors in multiple sclerosis (MS). HLA-G inhibits the effecter function of T cells and natural killer (NK) cells. Also regulatory T cells (Treg) are considered as pivotal players in MS pathogenesis. Thus, we aimed to evaluate the presence of HLA-G molecules and Treg cells in Relapsing...

Journal: :Neurology 2012
Massimiliano Calabrese Mi Sun Oh Alice Favaretto Francesca Rinaldi Valentina Poretto Sara Alessio Byung-Chul Lee Kyung-Ho Yu Hyeo-Il Ma Paola Perini Paolo Gallo

BACKGROUND Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease of the CNS in which a pathogenic role of anti-aquaporin-4 (AQP4) antibodies has been suggested. Although AQP4 is expressed in human cortex, recent histologic studies have failed to find any evidence of cortical demyelination in NMO. OBJECTIVE To evaluate, in vivo, the occurrence of focal and diffuse cortical ...

ژورنال: پژوهش در پزشکی 2018

Background: Previous studies suggest that retinal nerve fiber layer (RNFL) thickness decreases over time in multiple sclerosis (MS) and can be a marker of disease activity for patients’ follow-up. Here, we aimed to compare RNFL thickness in patients with relapsing remitting MS (RRMS) during three years of follow-up. Methods: During this prospective study, patients with diagnosis of RRMS and hi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید